Skip to main navigation
Skip to search
Skip to main content
UK Health Security Agency Main
Main
Profiles
Research units
Projects
Research output
Prizes
Activities
Impacts
Search by expertise, name or affiliation
Issues in antifungal susceptibility testing
Elizabeth M. Johnson
*
*
Corresponding author for this work
Bristol Mycology Reference Laboratory General
Research output
:
Contribution to journal
›
Article
›
peer-review
53
Citations (Scopus)
Overview
Fingerprint
Fingerprint
Dive into the research topics of 'Issues in antifungal susceptibility testing'. Together they form a unique fingerprint.
Sort by
Weight
Alphabetically
Keyphrases
Antifungal Susceptibility
100%
Antifungal Agents
100%
Susceptibility Testing
50%
Pharmacokinetic Analysis
50%
Invasive Disease
25%
Interlaboratory
25%
Susceptible Strain
25%
Laboratory Results
25%
Clinical Outcomes
25%
In Vitro Resistance
25%
Confounding Factors
25%
Standardized Method
25%
Resistance Emergence
25%
Standardized Approach
25%
Treatment Course
25%
Fungal Isolates
25%
Intra-laboratory
25%
Identication
25%
In Vivo Activity
25%
Spectrum of Activity
25%
Effcacy
25%
Yeast Isolate
25%
Dene
25%
Systemic Agents
25%
Innate Resistance
25%
In Vitro-in Vivo Correlation (IVIVC)
25%
Systemic Antifungals
25%
Early Attention
25%
Antifungal Drug Resistance
25%
Medicine and Dentistry
Antifungal Susceptibility
100%
Antifungal Agent
100%
Clinician
33%
In Vitro
33%
Pharmacodynamics
33%
Antifungal Resistance
33%
Pharmacokinetics
33%
In Vitro In Vivo Correlation
33%
Systemic Antifungal Agent
33%
Diseases
33%
Immunology and Microbiology
Antifungal Susceptibility
100%
Pharmacokinetics
50%
Antifungal Resistance
50%
Pharmacodynamics
50%
Mould
50%
Pharmacology, Toxicology and Pharmaceutical Science
Antifungal Agent
100%
Drug Resistance
25%
Pharmacodynamics
25%
Mould
25%
Fungal Isolates
25%
Systemic Antifungal Agent
25%
Pharmacokinetics
25%
Diseases
25%